Decortication Plus Endovac Therapy Avoids Esophagogastric Disconnection In Delayed Conduit Perforation Causing Massive Pleural Contamination (ACS-CLINCON 2026) - Sep 22, 2026 - Pres time: Sep 27, 2026; 12:45 PM - 12:56 PM; Location: Room 201; In Person Only; "A 58-year-old female developed a 20mm posterior peri-carinal gastric conduit perforation two years after neoadjuvant chemoradiation, robotic McKeown esophagectomy and adjuvant nivolumab treatment for stage IIIB Siewert type II gastroesophageal junction adenocarcinoma...She tolerated diet advancement and demonstrated appropriate weight gain over four months of follow-up. Ultimately, EndoVAC therapy provided source control by draining contaminated spaces and collapsing extra-conduit cavity and promoted tissue healing through serial exchanges."
Gastroenterology • Gastroesophageal Junction Adenocarcinoma • Infectious Disease • Pneumonia • Respiratory Diseases • Solid Tumor
|
|
Kaity H. Tung, MD; Todd L.. Demmy, MD FACS; Moshim Kukar, MBBS FACS; Kenneth Patrick. Seastedt, MD FACS
|